Publication:
The effects of shared epitope on the clinical response to leflunomide inpatients with active rheumatoid arthritis

dc.contributor.authorsSaruhan-Direskeneli, G; Inanc, M; Fresko, I; Akkoc, N; Dalkilic, E; Erken, E; Karaaslan, Y; Kinikli, G; Oksel, F; Pay, S; Yucel, AE; Yazici, H; Konice, M; Direskeneli, H
dc.date.accessioned2022-03-12T15:59:00Z
dc.date.accessioned2026-01-10T18:33:05Z
dc.date.available2022-03-12T15:59:00Z
dc.date.issued2003
dc.identifier.doidoiWOS:000224551401211
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/224253
dc.identifier.wosWOS:000224551401211
dc.language.isoeng
dc.publisherB M J PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe effects of shared epitope on the clinical response to leflunomide inpatients with active rheumatoid arthritis
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage367
oaire.citation.startPage367
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume62

Files